Perinatal N(G)-Nitro-L-arginine methyl ester administration decreases anxiety- and depression-like behaviors in adult mice

Einstein (Sao Paulo). 2023 Dec 4:21:eAO0302. doi: 10.31744/einstein_journal/2023AO0302. eCollection 2023.

Abstract

Objective: We hypothesized that perinatal manipulations of the nitrergic system would affect adult animal behaviors.

Methods: We tested this hypothesis by perinatally administering N(G)-Nitro-L-arginine methyl ester (L-NAME), a non-specific antagonist of nitric oxide synthase for 15 days and assessed anxiety- and depression-like behaviors in adult mice. At 70 days of age, the mice were subjected to a battery of tests consisting of the open-field, light/dark box, forced swim, and tail-flick tests. The tests were performed at two-day intervals, and the order of the tests within the battery was determined according to the progressive invasiveness degree.

Results: L-NAME-treated animals exhibited decreased anxiety-like behavior in the light/dark box and open field tests, with no change in locomotor activity. Additionally, they demonstrated decreased depression-like behavior in the forced swim test and no change in pain perception in the tail-flick test.

Conclusion: The nitrergic system is possibly involved in neural circuitry development that regulates behaviors since blocking perinatal nitric oxide production decreases anxiety- and depression-like behaviors in adult mice.

MeSH terms

  • Animals
  • Anxiety* / drug therapy
  • Behavior, Animal
  • Depression* / drug therapy
  • Mice
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide
  • Swimming

Substances

  • NG-Nitroarginine Methyl Ester
  • Nitric Oxide